Clinical Trial Update: CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency [NA]

View source ↗

Summary

Clinical trial update on using cytomegalovirus-specific donor-derived T lymphocytes to treat recalcitrant cytomegalovirus infection in a patient with primary im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Pneumonia
• T-cell Immunodeficiency

Drugs mentioned

• CMV-specific donor-derived T lymphocytes

Snippet

Sponsor: University of Calgary | Conditions: Cytomegalovirus Viremia, Cytomegalovirus Pneumonia | NA | Status: ACTIVE_NOT_RECRUITING